AltPep

Biotechnology Research • Seattle, Washington, United States • 21-50 Employees

Company overview

Headquarters	100 NE Northlake Way, Suite 300, Seattle, Washington 98105, US
Phone number	+14256580277
Website	altpep.com
Keywords	Biotechnology, Alzheimer'S Disease, Amyloid Disease
Founded	2019
Employees	21-50
Socials

Key Contacts at AltPep

Valerie Daggett

Founder And Ceo

Chandresh Gajera

Director, In Vivo And Translational Biology

Jeff Posakony

Senior Director Of Translational Chemistry

AltPep Email Formats

AltPep uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@altpep.com), used 64.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@altpep.com	64.3%
{first name}{last name}	johndoe@altpep.com	32.1%
{last name}{last name}	doedoe@altpep.com	3.6%

About AltPep

AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach. Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.

AltPep revenue & valuation

Annual revenue	$1,100,000
Revenue per employee	$33,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,600,000
Total funding	$52,900,000